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During early development, testosterone plays an important role in sexual differentiation of the mammalian brain
and has enduring influences on behavior. Testosterone exerts these influences at times when the testes are active,
as evidenced by higher concentrations of testosterone in developing male than in developing female animals. This
article critically reviews the available evidence regarding influences of testosterone on human gender-related
development. In humans, testosterone is elevated in males from about weeks 8 to 24 of gestation and then again
during early postnatal development. Individuals exposed to atypical concentrations of testosterone or other androgenic
hormones prenatally, for example, because of genetic conditions or because their mothers were prescribed hormones
during pregnancy, have been consistently found to show increased male-typical juvenile play behavior, alterations in
sexual orientation and gender identity (the sense of self as male or female), and increased tendencies to engage in
physically aggressive behavior. Studies of other behavioral outcomes following dramatic androgen abnormality
prenatally are either too small in their numbers or too inconsistent in their results, to provide similarly conclusive
evidence. Studies relating normal variability in testosterone prenatally to subsequent gender-related behavior have
produced largely inconsistent results or have yet to be independently replicated. For studies of prenatal exposures in
typically developing individuals, testosterone has been measured in single samples of maternal blood or amniotic fluid.
These techniques may not be sufficiently powerful to consistently detect influences of testosterone on behavior,
particularly in the relatively small samples that have generally been studied. The postnatal surge in testosterone in male
infants, sometimes called mini-puberty, may provide a more accessible opportunity for measuring early androgen
exposure during typical development. This approach has recently begun to be used, with some promising results
relating testosterone during the first few months of postnatal life to later gender-typical play behavior. In replicating
and extending these findings, it may be important to assess testosterone when it is maximal (months 1 to 2 postnatal)
and to take advantage of the increased reliability afforded by repeated sampling.
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This review critically evaluates the available evidence re-
garding the impact of two early surges of testicular hor-
mones on the development of human behaviors and
psychological characteristics that differ by sex. The re-
view begins by summarizing the large body of experi-
mental research in non-human animals that documents
the influences of testosterone on mammalian neurobe-
havioral development. These studies form the basis for
predicting that testosterone influences human neurobe-
havioral development, and their findings provide guidance
as to the types of effects that would be hypothesized to* Correspondence: MH504@cam.ac.uk
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unless otherwise stated.occur in humans. The next section of the review critically
evaluates research investigating the role of testosterone in
the development of human behavior. Because testosterone
would be expected to influence behaviors that show sex
differences, this section begins by reviewing evidence as to
which human behaviors show sex differences and dis-
cusses the sizes of the differences. Similarly, because tes-
tosterone would be expected to influence human sexual
differentiation at times when it differs in males and fe-
males, this section next summarizes information as to
when these times occur. The section also discusses meth-
odological approaches to studying possible influences of
testosterone on human development, given that proper
experiments, where individuals are randomly assigned tohis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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not ethically acceptable. The evidence that testosterone in-
fluences human neurobehavioral development prenatally
or neonatally is then evaluated. The review concludes by
summarizing various approaches and their pitfalls, by pro-
viding guidance for evaluating the robustness of studies
relating early testosterone to gender-related outcomes and
by suggesting that the early postnatal surge in testoster-
one, sometimes called mini-puberty, might be particularly
accessible for studying the role of testosterone in human
development.
Gonadal hormone influences on neurobehavioral
development in non-human mammals
Thousands of studies of non-human mammals have doc-
umented the contribution of gonadal steroids, particu-
larly the testicular hormone, testosterone, to sexual
differentiation of the brain and of behavior [1]. Female
animals treated with testosterone prenatally or neo-
natally subsequently show increased male-typical behav-
ior and decreased female-typical behavior. Similarly,
male animals that have their testes removed early in de-
velopment later show increased female-typical behavior
and reduced male-typical behavior. These effects have
been seen for sexual behaviors and for non-reproductive
behaviors that differ by sex, such as aggression and ju-
venile rough-and-tumble play [2]. They also have been
seen in numerous species ranging from rodents to non-
human primates [1,2].
Early hormone manipulations produce changes in the
mammalian brain as well as in behavior. The sexually di-
morphic nucleus of the preoptic area (SDN-POA) pro-
vides a prototypical example of these effects. The SDN-
POA is larger in volume and contains more neurons in
male than in female rats. Treating female rats with tes-
tosterone during early development increases SDN-POA
volume in adulthood and castrating developing males re-
duces it [3]. Testosterone and hormones produced from
it have been found to influence cell survival, neurite out-
growth, and neurochemical specification during early de-
velopment in rodents [4]. The effects of early androgen
exposure on both the brain and behavior are often de-
scribed as organizational, and early androgen exposure
is thought to produce enduring changes in behavior by
altering the development and organization of underlying
brain circuits.
Several general principles have emerged from the
thousands of studies of androgenic influences on devel-
opment in non-human mammals, and these principles
can guide studies evaluating the possibility of similar in-
fluences on the human brain and on human behavior.
First, the brain regions and behaviors that are influenced
show sex differences, meaning that they differ on the
average for male and female animals. Therefore, onlythose human behaviors that show sex differences would
be expected to relate to early androgen exposure. Sec-
ond, the periods when testosterone influences develop-
ment correspond to times when testosterone is higher in
developing male than in developing female animals.
Therefore, investigating testosterone in humans at times
when it shows dramatic sex differences provides the best
opportunity to see any effects that might exist. Third,
testosterone can contribute to individual differences
within each sex in gender-related characteristics, as well
as to differences between the sexes, and the influences
of testosterone are generally linear and graded, with in-
creasing doses of testosterone producing increasingly
large effects. Treatment outside the physiological range
can sometimes produce non-linear effects, perhaps be-
cause of feedback mechanisms that reduce endogenous
hormone production or because of full receptor occupa-
tion. Thus, when studying humans, the influences of tes-
tosterone within the physiological range would be
expected to be linear, with higher concentrations of tes-
tosterone relating to more male-typical, or less female-
typical, behavior. Outside the physiological range, testos-
terone exposure might have no effect, however, or even
the reverse effect to that seen at lower concentrations.
Evaluating the human evidence
Before beginning the review of human research, it is use-
ful to define some terms, point out some potential pit-
falls in studying human gender-related behavior, and
discuss some current concerns about the reliability of
findings in the biomedical sciences generally. We will
use the terms “gender difference” and “sex difference”
interchangeably to describe the average differences in
the behavior of males and females. We will also some-
times use the terms “behavior” and “psychological char-
acteristics” interchangeably, to describe one or the other
of these, or both. Regarding potential pitfalls in studying
gender, one is the tendency to analyze findings by gen-
der, even when there was no initial hypothesis about
gender differences [5]. This tendency, combined with
the tendency to publish significant, but not insignificant,
findings can lead to an over-reporting of gender differ-
ences. A second potential pitfall relates to correlational
analyses. When two characteristics each show a gender
difference, they will often correlate significantly in mixed
groups of males and females, simply because both char-
acteristics differ by gender. Therefore, in correlational
studies, it is important to analyze data within each sex,
rather than only in males and females combined. Re-
garding concerns about research reliability, flexibility in
analytic approaches and data inclusion/exclusion prac-
tices allows virtually any data set to produce statistically
significant results [6], and it has been suggested that
most published research findings in the biomedical
Figure 1 Median urinary testosterone concentrations in male
and female infants from 7 days to 6 months of age. Error bars
represent the interquartile range. Testosterone was measured at day
7 postnatal (D7) and then monthly from 1 month (M1) to 6 months
(M6) of age. Urinary testosterone was measured using HPLC-tandem
mass spectrometry. Urinary testosterone concentrations are higher in
boys than in girls, and testosterone peaks in boys at 1 month of age, is
lower before and after this age, and declines to baseline by about age
6 months. The figure is reproduced from [78] by permission of Elsevier.
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this review will point out which findings have been inde-
pendently replicated and which have not. Attention also
will be drawn to findings when they differ from those re-
ported by others and when they are inconsistent with
what would be hypothesized based on the experimental
findings in other species.
Which human behaviors show average sex differences?
There have been numerous meta-analyses of human be-
havioral sex differences. A review of these meta-analyses
concluded that men and women and boys and girls gen-
erally behave similarly, with most behaviors showing
negligible or small gender differences [8]. There are
some notable areas of difference, however. In all cases,
distributions for males and females overlap, but for some
behaviors, males and females differ more substantially
than for others [9]. The sizes of the differences in spe-
cific characteristics can be expressed in standard devi-
ation units. To put these units in a familiar context, the
sex difference in height is two standard deviation units
in size. Some psychological sex differences are larger
than the sex difference in height, but most are smaller.
For instance, the tendency to have a primary erotic at-
traction to females is many times as large in males as in
females (d = 5.0 to 6.0), as is the sex difference in identi-
fying with the male gender (d > 10.0), and both of these
sex differences are substantially larger than the sex dif-
ference in height. In contrast, sex differences in person-
ality characteristics, such as empathy or physical
aggression, and in cognitive abilities, such as mental ro-
tations or verbal fluency, are smaller. For instance, the
largest well-established cognitive sex difference is that
seen in performance accuracy on a specific three-
dimensional (3D) mental rotations task (d = 0.9, favoring
males); whereas the sex difference in verbal fluency is
relatively small (d = 0.3, favoring females). Sex differ-
ences on specific measures of personality characteristics,
such as empathy (higher in females than in males) and
aggression (higher in males than in females) also range
from about d = 0.2 to d = 1.0. Sex differences in child-
hood play behavior, such as preferences for toys like ve-
hicles and dolls or responses on inventories measuring a
range of gender-typed play activities, can be as large or
somewhat larger than the sex difference in height (d =
1.8 to 2.8). (See [2,9,10] for more detailed reviews of the
sizes of specific behavioral and psychological gender dif-
ferences). In the broader context of any type of group
difference in psychological characteristics, differences of
half a standard deviation (d = 0.5) are considered to be
of moderate size, those of 0.8 or greater are considered
to be large, and those of about 0.2 are considered to be
small. Differences smaller than 0.2 are viewed as negli-
gible [11]. For correlations, r values of 0.5 are consideredto be large, those of 0.3 are considered to moderate, and
those of 0.1 are considered to be small.
In addition to average differences in some aspects of
the behavior of males and females, there are sex differ-
ences in the likelihood of being diagnosed with certain
psychiatric disorders [12]. Males are more likely than fe-
males to be diagnosed with autism spectrum disorders
(ASD), with Tourette syndrome and other tic-related
disorders, with attention deficit/hyperactivity disorder
(ADHD) and with conduct disorder. In contrast, from
adolescence on, females are more likely than males to be
diagnosed with depression. Females also are more likely
than males to be diagnosed with eating disorders.
When during early development, does testosterone differ in
males and females?
Testosterone is notably higher in males than in females
during two periods of early human development - from
about weeks 8 to 24 of gestation - and during the first
few months after birth [13-15]. These, therefore, are the
times when testosterone is likely to influence human
gender development. In addition, the sex difference in
testosterone in infants appears to be largest at about the
first to the second month of postnatal life and to be
smaller before and after that, reaching baseline by about
6 months of age [13-15] (also see Figure 1).
How can hormonal influences on human development
be studied?
It generally is unethical to manipulate testosterone during
early human development for experimental purposes.
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veloped in unusual hormone environments, including in-
dividuals with genetic conditions, individuals whose
mothers were prescribed hormones during pregnancy, and
boys who were reassigned as girls early in life, because of
penile damage. A second approach has been to relate early
testosterone concentrations in typically developing indi-
viduals to later gender-related behavior. Studies also have
related the ratio of the second to the fourth digit of the
hand to sex-typical behavior, on the assumption that this
digit ratio reflects prenatal androgen exposure. The rela-
tionship of finger ratios to prenatal androgen exposure ap-
pears to be too weak to be useful in studies of typically
developing individuals, however, and studies relating fin-
ger ratios to sex-typed behavior have produced inconsist-
ent results [9,16,17]. Consequently, studies using finger
ratios to assess prenatal androgen exposure are not in-
cluded in this review.
Evidence from individuals exposed to unusual hormone
environments prenatally
The strongest evidence that prenatal androgen exposure
contributes to human gender development comes from
studies of children’s gender-typed play. Girls exposed to
elevated androgens prenatally, because they have the
genetic condition, congenital adrenal hyperplasia (CAH),
show increased male-typical toy, playmate, and activity
preferences, a finding replicated in over a dozen studies
from several independent research groups in several dif-
ferent countries, including the United States, the United
Kingdom, Sweden, and Germany [18].
Because these results are not from controlled experimen-
tal studies, it is important to consider whether the beha-
vioral differences between girls with and without CAH
might result from factors related to the CAH condition
other than prenatal androgen exposure. For instance, chil-
dren with CAH experience reduced corticosteroids pre-
natally and girls with CAH are born with some degree of
genital ambiguity, caused by their prenatal androgen expos-
ure. Children with CAH are treated with corticosteroids
postnatally to normalize their hormone levels. Behavioral
masculinization in girls with CAH is unlikely to be caused
by corticosteroid abnormality or treatment, however, be-
cause boys with CAH have similar corticosteroid abnormal-
ity and treatment (although their androgen levels appear to
be largely normal prenatally), but they do not show in-
creased behavioral masculinization. Evidence that healthy
children whose mothers were prescribed androgenic pro-
gestins during pregnancy show increased male-typical play,
and that those whose mothers were prescribed anti-
androgenic hormones show reduced male-typical play
[19-22], also suggests that androgen exposure, rather than
other aspects of the CAH condition, are responsible for the
behavioral differences seen in girls with CAH. Similarly,data from individuals with another genetic condition,
complete androgen insensitivity syndrome (CAIS), also sug-
gest a contribution of early androgen exposure to male-
typical play behavior. These XY individuals have normally
functioning testes but are born with feminine-appearing ex-
ternal genitalia, because their cells are unable to respond to
the androgens produced by their testes. Adults with CAIS
recall engaging in reduced male-typical, and increased
female-typical, play behavior in childhood [23], and these
effects have been replicated by an independent research
group for children with CAIS as well [24]. Thus, several
lines of evidence converge on the conclusion that prenatal
exposure to androgenic hormones increases male-typical
play behavior in children. This convergent evidence is
important, because it suggests that the common factor
across the different study populations, androgen expos-
ure, is responsible for the behavioral outcomes, rather
than the other consequences of the individual situations
(e.g., corticosteroid abnormality, ambiguous external
genitalia) that are not shared across populations.
Women exposed to elevated androgens prenatally be-
cause of CAH also are less likely to be exclusively or al-
most exclusively heterosexual than are other women, a
finding that has again been independently replicated
cross-nationally [25-28]. Across studies, the majority of
women with CAH are exclusively or almost exclusively
heterosexual, but about 30% are not, a figure markedly
higher than the about 5% or fewer in the general popula-
tion. Individuals with CAIS almost always have a sexual
orientation toward men, consistent with their lack of ef-
fective androgen exposure, and this finding also has been
reported by more than one independent research group
[23,29]. Sexual orientation also has been reported for two
male infants who were reassigned as girls because of se-
vere penile damage in infancy. One of these individuals
had primary sexual interest in women in adulthood,
whereas the other had sexual interest in both women and
men [30,31]. Both outcomes are consistent with an influ-
ence of early androgen exposure on sexual orientation.
In regard to gender identity, or one’s sense of self as
male or female, exposure to high levels of androgens
prenatally has been linked to an increased likelihood of
developing a male gender identity, despite being reared
as a female [32]. A change to living as a man has been
observed in about 1% to 3% of women with CAH, as
well as in women with other genetic conditions causing
exposure to elevated concentrations of androgens during
early development [33-36], and again has been seen
cross-nationally. The strength of identification as female
also seems to be reduced in women and girls with CAH,
even when they do not wish to change to live as males
[28,37,38]. There also is evidence from more than one
research group that individuals with CAIS almost always
develop a female gender identity, consistent with their
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reassigned as girls following early damage to their penis
have also been followed up for gender identity. In one such
individual, gender identity was male, despite female sex of
rearing from 18 months of age [30]. In the other individual,
gender identity was female, following female sex of rearing
from 7 months of age [31]. This last finding suggests
powerful influences of the social environment on gender
identity, given the female gender identity with female sex
of rearing, despite male-typical early androgen exposure
and a Y chromosome. It is important to note, however, that
this finding is not only a single, as yet unreplicated, report,
but that it involves a single individual.
Evidence linking early androgen exposure to behaviors
other than sex-typed childhood play, sexual orientation,
and gender identity is not as strong, in most cases, be-
cause fewer studies have been conducted. Two independent
research groups have reported that females with CAH show
increased physical aggression, however [40-42]. Although
earlier reports had suggested no increase in fighting in girls
with CAH [43,44], these reports were based on small sam-
ples and used weak measures (e.g., unspecified or single
interview questions). Evidence from boys and girls exposed
to androgenic progestins prenatally, because their mothers
were prescribed these hormones during pregnancy, also
suggests a link between prenatal androgen exposure and
later physically aggressive behavior [45], but this finding has
not been independently replicated. It also is unusual in
finding that boys, as well as girls, show increased aggression
following prenatal exposure to androgenic progestins.
In regard to cognitive abilities linked to gender, reports
to date are inconsistent. For spatial abilities, two studies
have found that girls or women with CAH perform bet-
ter on measures of mental rotations [46,47], but several
others have not [48-51]. Sample size and measurement
reliability could explain some of the inconsistencies, but
the study using the largest sample and the measure that
shows the largest sex difference [49] did not find that fe-
males with CAH performed better than unaffected fe-
males on mental rotations. Similarly, one study found
that females with CAH performed worse than controls
on a verbal fluency task [50], but similar results were
not found in a second study [48]. There is even less evi-
dence regarding links between early androgen exposure
and other gender-related behaviors. One study found de-
creased empathy in females with CAH [40] and another
found increased autistic traits [52], but these findings
await independent replication attempts.
Evidence from studies of normal variability in testosterone
prenatally
Studies of normal variability in testosterone prenatally
include studies that have measured testosterone in ma-
ternal blood during pregnancy and studies that havemeasured testosterone in amniotic fluid. These studies
provide some evidence suggesting that normal variability
in prenatal testosterone exposure may relate to later
gender-typical behavior, although none of the findings
have yet been independently replicated.
Regarding testosterone in maternal blood, one study
found that maternal testosterone at mid-pregnancy posi-
tively predicted male-typical play behavior at 3 and ½
years of age for girls [53]. A similar relationship was not
seen for boys, however. A study from a different re-
search group found that maternal sex hormone-binding
globulin (SHBG; a protein which limits the availability of
testosterone to act), measured at a similar time during
pregnancy, in combination with testosterone in adult-
hood, positively predicted sex-typed behavior in adult fe-
male offspring [54]. Men were not included in this
study. We were able to find two studies that investigated
the relationship between maternal and fetal testosterone.
One study did not find a significant relationship between
maternal and fetal testosterone [55], but the second
study reported a significant positive correlation between
maternal and fetal testosterone (r = 0.42) [56].
Regarding testosterone measured in amniotic fluid,
one study has reported that testosterone measured in
amniotic fluid positively predicts male-typical play in
both boys and girls [57]. Two other studies have not
found a similar relationship, however [58,59]. It is not
clear whether these failures to see the relationship reflect
the use of smaller samples or less sensitive measurement
tools or whether the relationship between testosterone in
amniotic fluid and sex-typical childhood play is weak or
non-existent. Other data suggest that amniotic fluid tes-
tosterone may not be a reliable measure of fetal androgen
exposure. The one study that we have been able to find
that related testosterone in amniotic fluid to testosterone
in fetal blood did not find a significant correlation [55].
Researchers have also looked at relations between nor-
mal variability in amniotic fluid testosterone and perform-
ance on spatial tasks. Two studies found no significant
correlation between amniotic fluid testosterone and accur-
acy scores on a mental rotation task in either boys or girls
[60,61]. One of the studies [60] is frequently cited as sup-
porting the idea that prenatal testosterone exposure influ-
ences spatial ability, and so it merits a closer look. The
measure of mental rotations used in the study did not
show a statistically significant sex difference in the usual
outcome variable, accuracy. In addition, the authors
subdivided their samples of girls and boys into those
who appeared to be using a rotational approach and
those who did not, in an exploratory fashion, and re-
ported findings only for these four subgroups, ranging
in size from 7 to 13 children, and not for the full groups
of 21 girls and 20 boys. Also, they looked at three per-
formance variables, in addition to accuracy, variables
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ences. Significant findings included a positive correl-
ation between amniotic fluid testosterone and speed of
rotation among girls who were judged to be using a
rotational strategy, but a negative relationship in boys
who were judged to be using a rotational strategy. These
are the findings that are typically cited to support an ef-
fect of early androgen exposure on spatial abilities. The
findings are in opposite directions; however, and neither
finding would have been predicted based on previously
reported patterns of sex differences or on sex differ-
ences in the study itself, since speed of rotation did not
show a sex difference. A different research group has re-
ported a significant correlation between amniotic fluid
testosterone and performance on an embedded figure
task [61]. The large sex difference seen on the task in
this study (d = 1.15) contrasts with prior meta-analytic
research [62,63] showing small sex differences on this
type of task. As noted above, this study also found no
correlation between amniotic fluid testosterone and
performance on a mental rotation task. This negative
result occurred even though the mental rotation task
showed a sex difference of reasonable size (d = 0.6).
One research group also has looked at the correlation
between amniotic fluid testosterone and a range of char-
acteristics related to ASD in subgroups from a popula-
tion of several hundred children for whom testosterone
had been measured in amniotic fluid. These studies also
merit careful examination, because they are widely cited
to support a contribution of early androgen exposure to
ASD. Different reports from this group are based on dif-
ferent subsamples from the larger population, with the
subsamples ranging in size from about 20 individuals of
each sex to about 100 individuals of each sex, depending
on the study. An initial study found a correlation be-
tween amniotic fluid testosterone and reduced vocabu-
lary in girls and boys combined [64], but both variables
showed a sex difference and correlations were not signifi-
cant within either girls or boys. Thus, the significant find-
ing might simply reflect the existence of a sex difference
on each of the two measures. A second study reported a
significant curvilinear relation between amniotic fluid
testosterone and eye contact in boys but not in girls
[65], but this curvilinear relationship, as opposed to a
linear relationship, had not been predicted. These stud-
ies were part of a larger project that also measured look-
ing preferences for social/non-social stimuli, non-verbal
communicative gestures, verbalizations, pretend play,
and empathy [66]. None of these other measures related
significantly to amniotic fluid testosterone in either girls
or boys. The numerous measures, the small sample size
and the single, unpredicted, statistically significant
within-sex relationship observed, suggest the possibility
of chance findings.Subsequent studies from the same research group have
reported significant relationships between amniotic fluid
testosterone and various measures of empathy that show
sex differences favoring girls, and on questionnaires asses-
sing restricted interests, systemizing, and characteristics
related to autism, on which boys typically score higher
than girls. One study found a significant negative correl-
ation between amniotic fluid testosterone and scores on
the Child Version of the Empathizing Quotient in boys
but not in girls [67]. This study also found negative corre-
lations between amniotic fluid testosterone and perform-
ance on a measure of judging emotions in eyes, for boys
and for girls. A second study found no significant correl-
ation in either boys or girls between amniotic fluid testos-
terone and performance on a measure of empathy that
involved describing interactions between animated trian-
gles [68]. The same research group also found that amni-
otic fluid testosterone correlated with restricted interests
in boys, though not in girls [69], and with scores on the
Systemizing Quotient—Child Version [70] in boys and in
girls. Similarly, they have reported significant correlations
between amniotic fluid testosterone and scores on the
Child Autism Spectrum Quotient and the Quantitative
Checklist for Autism in Toddlers in boys and in girls
[71,72] and on the Childhood Autism Spectrum Test in
boys but not in girls [71]. There have been no reported in-
dependent replication attempts, at least as yet, for these
findings of relationships between amniotic fluid testoster-
one and empathy, restricted interests, or scores on mea-
sures of characteristics related to ASD.
Most recently, this research group has reported that
testosterone measured in amniotic fluid does not relate
to a diagnosis of ASD [73]. This study examined testoster-
one and four other hormones in amniotic fluid for 128
males diagnosed with ASD compared to 217 male controls.
Data for girls with and without ASD were not reported.
Amniotic fluid testosterone did not differ significantly for
males with and without ASD, nor did androstenedione,
progesterone, 17 alpha-hydroxy-progesterone, or cortisol.
Instead, a principal component, extracted from values for
all five hormones, was higher in boys with a diagnosis of
ASD. Although these findings do not support suggestions
that ASD relates to early testosterone or androgen expos-
ure, they might suggest an alternative mechanism related
to hormones, although not one for which there is evidence
of a link to gender. These findings also await attempts at
independent replication.
Other disorders that show discrepant sex ratios have
not been the focus of as much research on possible links
to early testosterone exposure as have ASD. Similar
ideas have been put forward in regard to tic-related dis-
orders [74] and ADHD [75], however, both of which, like
ASD, are more often diagnosed in males than in females.
Evidence that individuals diagnosed with tic-related
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pected in other areas that have been related to prenatal
androgen exposure, e.g., in their childhood play inter-
ests, has been suggested to provide some support for
prenatal androgenic influences on tic-related disorders.
As yet, suggestions that early testosterone exposure re-
lates to ADHD are largely theoretical. Eating disorders
are more common in females than in males, and it has
been suggested that testosterone exposure during early
development might protect against these disorders [76].
Findings of reduced disordered eating in females with
male co-twins compared to females with female co-twins
have been interpreted to support this hypothesis, based on
the assumption that females with male co-twins are ex-
posed to some of their male co-twin’s testosterone [76]. A
second team of researchers failed to replicate this finding,
however [77], although this replication attempt used a dif-
ferent measure to assess disordered eating.
Thus, although a primary basis for interest in under-
standing the influences of testosterone on human behav-
ior has been the idea that androgens might contribute to
discrepant sex ratios for psychological diagnoses, re-
search in this area has been relatively scant for disorders
other than ASD, and for ASD has ultimately produced
findings that do not support a contribution from pre-
natal testosterone exposure. This lack of research, and
even the lack of clearly supportive findings, might re-
flect, in part, the rarity of individuals with both atypical
androgen exposure during early development and a
gender-linked psychological diagnosis and the lack of a
powerful measure of prenatal androgen exposure in indi-
viduals without hormone abnormality. The measures of
prenatal testosterone exposure that have been used in
typically developing individuals, including measurements
of testosterone in amniotic fluid, and comparing individ-
uals with male versus female co-twins, may not be
powerful enough to detect effects consistently in the
sample sizes available.
The early postnatal testosterone surge and human behavior
The early postnatal surge in testosterone, sometimes
called mini-puberty, may be more accessible than the
prenatal surge. One study measured testosterone repeat-
edly in urine samples from infants beginning at week 1
and continuing each month from weeks 4 to 26 of post-
natal life (months 1 to 6 postnatal) (Figure 1). Gender-
typical play was then measured using a questionnaire,
the Pre-School Activities Inventory (PSAI), and by ob-
serving toy choices in a playroom at age 14 months. The
area under the curve for testosterone during the first
6 months of life was significantly larger in boys than in
girls. In addition, the area under the curve for testoster-
one positively predicted PSAI scores for male-typical
play, negatively predicted observed play with a baby dollin boys, and positively predicted observed play with a
train in girls [78]. There have not yet been any attempts
at independent replication of these findings.
Other researchers have measured salivary testosterone
in infants at the age of 3 to 5 months and measured be-
havior either on the same day [79,80] or later in life [72].
None of these studies found a significant sex difference
in testosterone, perhaps because the samples were taken
on only a single occasion when infants were 3 to
5 months of age, after the peak of the early postnatal
surge. Testosterone appears to be highest at the first
month of postnatal life and to have declined substan-
tially by about the third to fourth month (Figure 1). The
single, rather than repeated, measurement might have
further reduced the power of these studies. The studies
looking at behavior on the same day as saliva sampling
have reported some correlations between testosterone
and behavior. These correlations involved behaviors that
do not show sex differences, however, and so would not
be predicted to relate to testosterone. The study that
measured behavior later in life found no relationship be-
tween testosterone in saliva and scores on the Quantita-
tive Checklist for Autism in Toddlers [72]. The relatively
late, single assessment of postnatal testosterone might
have contributed to this negative result.
Conclusions
The relationship of finger ratios to prenatal androgen
exposure appears to be too weak to be useful in studies
attempting to relate prenatal androgen exposure to later
behavior [9,16,17], and this review suggests that this may
be the case for testosterone measured in amniotic fluid
as well. Although one research group has found pre-
dicted relationships, others have not. Small sample sizes
may have contributed to the failures to find significant
effects, but the insignificant correlation that has been re-
ported between testosterone in fetal blood and testoster-
one in fetal amniotic fluid [55] also does not support the
robustness of the amniotic fluid approach.
Researchers have recently begun to measure testoster-
one in early infancy, during the early postnatal testoster-
one surge. This approach to understanding relations
between early androgen exposure and human gender de-
velopment has two advantages. First, in contrast to ma-
ternal blood or amniotic fluid, it provides measures from
the developing individual him or herself. Second, the
postnatal surge can be sampled on repeated occasions
and sampling can be controlled for time of day.
So far, behavioral researchers have measured testosterone
during infancy in urine or in saliva, and urine measures,
but not saliva measures, have shown a sex difference. How-
ever, in these studies, saliva samples were obtained on only
one occasion, whereas in the study using urine samples,
they were obtained repeatedly, on seven occasions between
Hines et al. Biology of Sex Differences  (2015) 6:3 Page 8 of 10birth and 6 months of age. In addition, saliva samples were
obtained only after the peak in testosterone, further limit-
ing the potential to detect sex differences. Repeated sam-
pling between about 4 to 8 weeks of age, at controlled
times of day, is likely to provide the best chance of detect-
ing sex differences in testosterone, as well as relationships
to later gendered behavior.
Recommendations for future studies aimed at evaluating
the influence of early androgen exposure on human be-
havior echo those described elsewhere [16,81,82]. These
recommendations include focusing on behaviors that
show sex differences and hypothesizing linear effects, par-
ticularly within the physiological range. Recommendations
for correlational studies also include analyzing correlations
within each sex, rather than in the sexes combined, to re-
duce spurious findings. It has been argued that most re-
search findings in the biomedical sciences are false [6,7].
The guidelines for conducting research on relationships
between testosterone and behavior can also be adapted to
help researchers evaluate whether findings in this area are
likely to be replicable. Confidence in replicability is in-
creased if a study 1) assesses outcome variables that show
sex differences; 2) assesses testosterone at a time when it
is higher in developing males than females; 3) looks at re-
lationships in males and females separately; and 4) finds
linear relationships within the physiological range. Other
more general recommendations for avoiding spurious
findings also apply to this area of research, including
reporting all groups and all variables that were assessed,
and indicating how sample sizes were determined. If this
research area is to develop into a more mature science, it
will also be important to replicate effects and report both
significant and insignificant findings to facilitate meta-
analysis and estimation of effect sizes.
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